The Native Antigen Company is an expert in the production of bacterial and viral antigens, specialising in the development and manufacture of native and recombinant viral and bacterial antigens.
The company’s antigens are used by pharmaceutical and IVD manufacturers in vaccine research and serology where proper folding and glycosylation are vital. As well as offering antigens from a rapidly expanding portfolio, the company undertakes bespoke product development and custom manufacture using its mammalian cell protein expression system.
The company provides natively produced, high-purity antigens and toxins presented in a variety of formats, including: glycerol, frozen, lyophilised and as cell lysates. The available bacterial antigens include Bordetella pertussis, Chlamydia, Clostridium difficile, Mycoplasma, Neisseria gonorrhoeae and Vibrio cholerae.
The company produces viral antigens from a range of established and emerging viral diseases which include: chikungunya virus, Crimean-Congo haemorrhagic fever virus, Ebola virus, EBV, HIV, influenza virus, Lassa Fever virus, Mayaro virus, Oropouche virus, Parvovirus, respiratory syncytial virus, Vaccinia virus, Japanese encephalitis virus, tick-borne encephalitis virus, Usutu virus, Zika virus, adenovirus, astrovirus, CMV, dengue virus, HSV, West Nile virus and yellow fever virus.
Original Article: The Native Antigen Company bacterial and viral antigens